Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.
about
Oligometastasis and oligo-recurrence: more than a mirageOligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAsUpregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture modelSuppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cellsThe transcriptional profiling of glycogenes associated with hepatocellular carcinoma metastasisEstablishment and characterization of human hepatocellular carcinoma cell line FHCC-98.Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinomaRegulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis.Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells.A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospectsHerbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice.Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma.Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validationDecreased expression of acetyl-CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristicsEstablishment of animal models with orthotopic hepatocellular carcinoma.A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma.The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer ModelsOligometastatic breast cancer: A mini review.Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy.Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition processAn N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers.A feedback inhibition between miRNA-127 and TGFβ/c-Jun cascade in HCC cell migration via MMP13EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human CancersIPA-3 inhibits the growth of liver cancer cells by suppressing PAK1 and NF-κB activation.RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo.Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinomaThe Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistanceN-glycoproteome analysis of the secretome of human metastatic hepatocellular carcinoma cell lines combining hydrazide chemistry, HILIC enrichment and mass spectrometryHigh expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma.Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma.Phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, MHCC97-HInduction of tumor initiation is dependent on CD44s in c-Met⁺ hepatocellular carcinomac-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinomaKnockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells.The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.
P2860
Q26828767-11C2CD46-8577-4B6B-A729-5390CD56F67CQ27334649-4085A640-711D-4ECA-875A-31375CE4940AQ28114928-A692FFE3-887E-4D46-B6FF-8C77B3749D2BQ28485238-2901C6B9-79E4-4E67-B318-8DDD31E7B58AQ28543071-3D032777-3D65-42A1-9D12-0F4009DB6819Q30831603-D7C0D09A-C6C4-4E3C-A0E0-4A1BEE4988BCQ33376050-8DB48DBF-E91E-414E-AA7C-F74850B4A245Q33424107-07AEC679-C38A-4EF4-ABC7-05AE64214705Q33511020-E2BFEFCD-8C9E-4284-B629-8649EDD4F106Q33576268-1C0E8B51-0BAC-4FFF-B1B2-32A06F229DFEQ33582751-7B4787A0-40E6-4C79-BCD3-65DF56B41BB1Q33661037-D056596E-3615-46EE-9876-575E6FCB8C9CQ33726314-7274E35C-68D4-4046-8BBB-0075E5935FE3Q33732998-7F8155AA-1566-4CD6-8C9E-AE1841070DBAQ33751830-50764B69-CBF9-4F48-B2F8-8C287D1480D8Q33873296-CA6A48F1-EB4C-4BE9-B480-9F76C5092D9CQ33961542-28BE7773-EDFB-46D7-8345-9B6C0F05C6E8Q34022318-E4AE5B19-3AA6-4F2B-ACFB-086228E08FD9Q34090895-E91AC60D-DAC9-42CF-83BD-1A2BAEC398ECQ34184464-A5C1D91B-CE9E-4385-82A8-CEC76CD02CFCQ34309954-245F44D8-CF3E-4F20-82DD-26843BD415DBQ34368285-757CDC97-E500-49A8-A106-4DCBAA3E835AQ34544599-16F705E0-D96F-40A3-A4D9-93DFD262164BQ34611324-C8A3FB55-7B7C-4484-8691-876D463FE282Q34618415-D57C3368-2BF0-4308-BE81-EF3D86BACDC0Q34627182-E2A9175C-7908-4875-9F72-FC5A13D992E7Q34769755-E3DE28E1-68F0-4AA0-9C56-90B25162AFFDQ34797908-D6DD8D58-E0DF-4F2A-A88B-21F5AC5E3DCEQ34873314-1CFDF11E-6C15-4B14-A6F8-8771AB8624E8Q34956767-0F1FD139-12F3-41FC-A4BF-E9F53ABDEE2FQ34957259-E825AF9C-4654-4DBB-8DD1-294F6700E8DEQ35045419-CE034A5A-D707-4312-97C9-FCF340981F27Q35064045-248DDE21-2C1D-4B7F-9F5F-C6A107BE3840Q35114504-D4F5D4FC-19AE-47F7-A56B-976935EC9B25Q35116051-61A4C301-1242-4042-B03D-BDA5A6D1084AQ35139225-EC3B150A-60F6-44E0-B22D-65ACBD554518Q35234688-C3D21F20-C347-493E-8C46-2D3FAE84CF78Q35235798-4B923B34-2E9C-4655-BF24-4353D909011FQ35387908-76DB4F2A-C740-4D46-8F2E-8252ABC6D59AQ35636713-19410BC3-CD68-4AA6-838A-0339976D9F79
P2860
Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Establishment of cell clones w ...... ar carcinoma cell line MHCC97.
@ast
Establishment of cell clones w ...... ar carcinoma cell line MHCC97.
@en
type
label
Establishment of cell clones w ...... ar carcinoma cell line MHCC97.
@ast
Establishment of cell clones w ...... ar carcinoma cell line MHCC97.
@en
prefLabel
Establishment of cell clones w ...... ar carcinoma cell line MHCC97.
@ast
Establishment of cell clones w ...... ar carcinoma cell line MHCC97.
@en
P2093
P2860
P1476
Establishment of cell clones w ...... ar carcinoma cell line MHCC97.
@en
P2093
P2860
P304
P407
P577
2001-10-01T00:00:00Z